YSP Southeast Asia Holding Bhd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares YSP Southeast Asia Holding Bhd with three other
companies in this sector in Malaysia:
sales of 169.94 million Malaysian Ringgits [US$43.69 million]
Kotra Industries Bhd
(166.37 million Malaysian Ringgits [US$42.77 million]
CCM Duopharma Biotech Berhad
(467.99 million Malaysian Ringgits [US$120.31 million]
of which 100%
was Manufacturing of Pharmaceutical Products).
YSP Southeast Asia Holding Bhd reported sales of 261.56 million Malaysian Ringgits (US$67.24 million)
December of 2017.
increase of 10.3%
versus 2016, when the company's sales were 237.07 million Malaysian Ringgits.
Sales at YSP Southeast Asia Holding Bhd have increased during each of the previous five years
(and since 2012, sales have increased a total of 45%).